127 related items for PubMed ID: 38123128
21. Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute.
Shen SC, Shen CC, Pu TW, Cheng WY.
World Neurosurg; 2019 Jun; 126():e41-e47. PubMed ID: 30716503
[Abstract] [Full Text] [Related]
22. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[Abstract] [Full Text] [Related]
23. Delayed Remission of Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Adenectomy.
Wang Z, Guo X, Gao L, Feng C, Lian W, Deng K, Bao X, Feng M, Wang R, Xing B.
World Neurosurg; 2019 Feb; 122():e1137-e1145. PubMed ID: 30447463
[Abstract] [Full Text] [Related]
24. Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study.
Coopmans EC, Postma MR, Wolters TLC, van Meyel SWF, Netea-Maier R, van Beek AP, Neggers SJCMM.
J Clin Endocrinol Metab; 2021 May 13; 106(6):1783-1792. PubMed ID: 33544833
[Abstract] [Full Text] [Related]
25. Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study.
Locatelli D, Veiceschi P, Castelnuovo P, Tanriover N, Evliyaoglu O, Canaz H, Ugurlar D, Gazioglu N.
Childs Nerv Syst; 2019 Nov 13; 35(11):2119-2126. PubMed ID: 31079182
[Abstract] [Full Text] [Related]
26. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
Tindall GT, Oyesiku NM, Watts NB, Clark RV, Christy JH, Adams DA.
J Neurosurg; 1993 Feb 13; 78(2):205-15. PubMed ID: 8421204
[Abstract] [Full Text] [Related]
27. The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes.
Buliman A, Tataranu LG, Ciubotaru V, Cazac TL, Dumitrache C.
J Med Life; 2016 Feb 13; 9(2):187-92. PubMed ID: 27453753
[Abstract] [Full Text] [Related]
28. Intraoperative magnetic resonance imaging-assisted transsphenoidal pituitary surgery in patients with acromegaly.
Bellut D, Hlavica M, Schmid C, Bernays RL.
Neurosurg Focus; 2010 Oct 13; 29(4):E9. PubMed ID: 20887134
[Abstract] [Full Text] [Related]
29. Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly.
Park SH, Ku CR, Moon JH, Kim EH, Kim SH, Lee EJ.
J Clin Endocrinol Metab; 2018 Mar 01; 103(3):909-916. PubMed ID: 29272449
[Abstract] [Full Text] [Related]
30. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
Abbassioun K, Amirjamshidi M, Mehrazin A, Khalatbary I, Keynama M, Bokai H, Abdollahi M.
Surg Neurol; 2006 Jul 01; 66(1):26-31; discussion 31. PubMed ID: 16793431
[Abstract] [Full Text] [Related]
31. Preoperative prediction of granulation pattern subtypes in GH-secreting pituitary adenomas.
Heng L, Liu X, Jia D, Guo W, Zhang S, Gao G, Gong L, Qu Y.
Clin Endocrinol (Oxf); 2021 Jul 01; 95(1):134-142. PubMed ID: 33738801
[Abstract] [Full Text] [Related]
32. Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype.
Lee CC, Vance ML, Lopes MB, Xu Z, Chen CJ, Sheehan J.
Pituitary; 2015 Jun 01; 18(3):326-34. PubMed ID: 24925503
[Abstract] [Full Text] [Related]
33. Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion.
Park HH, Kim EH, Ku CR, Lee EJ, Kim SH.
World Neurosurg; 2018 Sep 01; 117():e280-e289. PubMed ID: 29906579
[Abstract] [Full Text] [Related]
34. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
World Neurosurg; 2017 Dec 01; 108():278-290. PubMed ID: 28887283
[Abstract] [Full Text] [Related]
35. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome.
Jane JA, Starke RM, Elzoghby MA, Reames DL, Payne SC, Thorner MO, Marshall JC, Laws ER, Vance ML.
J Clin Endocrinol Metab; 2011 Sep 01; 96(9):2732-40. PubMed ID: 21715544
[Abstract] [Full Text] [Related]
36. Transsphenoidal Surgery for Mixed Pituitary Gangliocytoma-Adenomas.
Shepard MJ, Elzoghby MA, Ghanim D, Lopes MBS, Jane JA.
World Neurosurg; 2017 Dec 01; 108():310-316. PubMed ID: 28887280
[Abstract] [Full Text] [Related]
37. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD.
Eur J Endocrinol; 2015 Jun 01; 172(6):707-13. PubMed ID: 25792375
[Abstract] [Full Text] [Related]
38. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L, Starke RM, Jane JA, Oldfield EH.
J Neurosurg; 2015 Apr 01; 122(4):798-802. PubMed ID: 25423276
[Abstract] [Full Text] [Related]
39. Prospective Integrated Individualized Clinical Decision-making and Outcome Evaluation for Surgery in Patients with Acromegaly: A New Paradigm?
Verstegen MJT, Bakker LEH, de Vries F, Schutte P, Pelsma ICM, van Furth WR, Biermasz NR.
Arch Med Res; 2023 Dec 01; 54(8):102918. PubMed ID: 38007381
[Abstract] [Full Text] [Related]
40. Endoscopic endonasal approach for acromegaly: surgical outcomes using 2018 consensus criteria for remission.
de Carvalho Cavalcante RA, Vieira LA, Peres LFA, Zaccariotti AJ, de Sousa Alencar H, Jatene EM, Camargo LA, Dias Rodrigues ML.
Arch Endocrinol Metab; 2023 Jun 19; 67(6):e000650. PubMed ID: 37364152
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
